ArticleTherapeutic advances in musculoskeletal disease2022

Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.

Carmen Álvarez-Reguera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.